Skip to main content
AstraZeneca Pharma India Ltd. logo

AstraZeneca Pharma India Ltd. — Investor Relations & Filings

Ticker · ASTRAZEN ISIN · INE203A01020 LEI · 335800N8M7W5JDTAHR68 BSE.NS Manufacturing
Open in API
Filings indexed 1,263 across all filing types
Latest filing 2023-03-06 Regulatory Filings
Country IN India
Listing BSE.NS ASTRAZEN

About AstraZeneca Pharma India Ltd.

https://www.astrazeneca.com/content/az-…

AstraZeneca Pharma India Ltd. is a science-led biopharmaceutical organization dedicated to the discovery, development, and commercialization of innovative prescription medicines. The company focuses on core therapeutic areas including Oncology, Cardiovascular, Renal & Metabolism, Respiratory & Immunology, and Rare Disease. Its product portfolio includes advanced treatments such as Tagrisso, Lynparza, and Imfinzi for various cancers, as well as Forxiga and Brilinta for metabolic and cardiovascular conditions. The company utilizes a robust global research pipeline to address complex medical challenges and improve patient outcomes. Through clinical research and specialized healthcare solutions, it delivers transformative therapies designed to treat chronic and life-threatening diseases. The organization is characterized by its commitment to scientific excellence and the delivery of high-value medical interventions.

Recent filings

Filing Released Lang Actions
We are enclosing herewith the Certificate dated March 3, 2023 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming ....
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Registrar and Transfer Agent confirming compliance with dematerialization and securities listing requirements for the period 01.02.2023 to 28.02.2023. It is addressed to stock exchanges and signed by the company secretary. The document is short (3251 characters) and primarily serves as a compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. It is not an announcement of a report publication but a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories.
2023-03-06 English
This is in continuation to our letter dated February 28, 2023, wherein it was stated that the Company has referred to its letter dated February 25, 2023, enclosing therewith Postal Ballot ....
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a letter addressed to stock exchanges clarifying a typographical error related to a previous communication about the declaration of voting results of a postal ballot and the scrutinizer's report. It references prior dates and documents but does not contain any financial data, detailed voting results, or the actual report itself. The document is short (1833 characters) and serves as a correction or clarification to an earlier announcement. Therefore, it is not the actual declaration of voting results but a clarification related to it. According to the classification rules, such a document fits best under Declaration of Voting Results & Voting Rights Announcements (DVA) because it pertains to voting results communications, even though it is a clarification. The confidence is high given the clear context and content.
2023-03-02 English
Updates
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a letter addressed to stock exchanges clarifying a typographical error related to a previous communication about the declaration of voting results of a postal ballot and the scrutinizer's report. It references prior dates and documents concerning voting results but does not itself contain voting results or financial data. The document is short (1833 characters) and serves as a clarification or correction to a previous filing. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it pertains to voting results and related communications. The document is not the original voting result declaration but a clarification related to it, which still falls under DVA rather than a general regulatory filing or report publication announcement because it directly concerns voting results information.
2023-03-02 English
Shareholders meeting
Regulatory Filings
2023-02-28 English
This is in reference to our letter dated February 25, 2023, enclosing therewith a Postal Ballot Notice dated February 24, 2023 seeking consent of the Members of the Company through Special ....
Regulatory Filings
2023-02-28 English
Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) providing contact details of Key Managerial Personnel authorized to determine materiality of events as per SEBI Listing Obligations and Disclosure Requirements. It is a regulatory compliance announcement rather than a financial report, meeting notice, or management change announcement. The document is short (1525 characters) and does not contain financial data, voting results, or executive compensation details. It is best classified as a Regulatory Filing (RNS) because it is a compliance disclosure that does not fit other specific categories.
2023-02-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.